British Journal of Radiology · 2000 · 18 citations · 7 references
MedicineNuclear MedicineOncologyBone ScintigraphyDiagnostic Nuclear MedicineMetastasisBone MetastasisBone Metastasis ImagingBone PathologyBone TumorsMetastatic Bone DiseaseMultiple Myeloma99Mtechnetium-labeled Bone-tracer ImagingBone-avid Tracer ScintigraphyMetastatic Bone Disease DetectionMultiple Myeloma-associated AmyloidosisOrgan UptakeRadionuclide Bone ImagingRadionuclide Bone ScintigraphyTc-99m Methylene Diphosphonate Imaging
Bone scintigraphy is not usually performed in multiple myeloma (MM), as marrow deposits characteristically show no tracer uptake. However, metastatic bone disease often mimics MM both clinically and biochemically, resulting in a substantial number of MM patients undergoing bone scintigraphy. Variable appearances in these cases have been reported, ranging from normal to a superscan, the latter a result of massive tracer uptake within bone. Soft tissue uptake has been documented, often when MM is complicated by secondary amyloidosis. This usually results in mainly solid organ uptake of tracer. We report a case of MM where massive soft tissue uptake occurred, primarily within muscles, with very little isotope elsewhere.
7
Multiple myeloma: Radiology or bone scanning?
Robert Leonard, J. P. Owen, SJ Proctor et al. · Clinical Radiology · 1981 · 33 citations
Medicine, Hematology, Radiology +14
Soft-tissue Uptake of Technetium-99m MDP in Multiple Myeloma
T Kanoh, Haruto Uchino, Itsuo Yamamoto et al. · Clinical Nuclear Medicine · 1986 · 14 citations